DENTSPLY International Inc.  

(Public, NASDAQ:XRAY)   Watch this stock  
Find more results for Michael G. Rinn
52.03
-0.12 (-0.22%)
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 51.45 - 52.13
52 week 43.83 - 56.25
Open 52.03
Vol / Avg. 788,901.00/769,575.00
Mkt cap 7.28B
P/E 23.85
Div/yield 0.07/0.56
EPS 2.18
Shares 139.82M
Beta 1.35
Inst. own 92%
Jul 29, 2015
Q2 2015 DENTSPLY International Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 27, 2015
DENTSPLY International Inc at Stifel Dental & Veterinary Conference
May 20, 2015
DENTSPLY International Inc Annual Shareholders Meeting
May 13, 2015
DENTSPLY International Inc at Bank of America Merrill Lynch Health Care Conference
May 6, 2015
Q1 2015 DENTSPLY International Inc Earnings Release
May 6, 2015
Q1 2015 DENTSPLY International Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 10.41% 11.06%
Operating margin 14.89% 15.25%
EBITD margin - 20.11%
Return on average assets 6.07% 6.65%
Return on average equity 11.42% 13.30%
Employees 11,600 -
CDP Score - 80 E

Address

221 W Philadelphia St
YORK, PA 17401-2991
United States - Map
+1-717-8457511 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Dentsply International Inc. is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The Company manufactures and markets other consumable medical device products. The Company’s product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company’s dental consumable products consist of value added dental supplies and devices and small equipment used in dental offices for the treatment of patients. The Company’s dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company’s dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company’s consumable medical device products consist mainly of urological products.

Officers and directors

Bret W. Wise Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Christopher Thomas Clark President, Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
James G. Mosch Chief Operating Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert J. Size Senior Vice President
Age: 56
Bio & Compensation  - Reuters
Albert J. Sterkenburg DDS Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Deborah M. Rasin Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
William F. Hecht Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
Michael C. Alfano Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Eric K. Brandt Independent Director
Age: 52
Bio & Compensation  - Reuters
Paula H. J. Cholmondeley Independent Director
Age: 67
Bio & Compensation  - Reuters